187
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Characteristics of Xerosis, Pruritus, and Pallor in Stage 5 Chronic Kidney Disease Patients Undergoing Hemodialysis at Dr. Hasan Sadikin General Hospital, Bandung

ORCID Icon, ORCID Icon, , , ORCID Icon, & ORCID Icon show all
Pages 2613-2621 | Received 11 Jun 2023, Accepted 05 Sep 2023, Published online: 21 Sep 2023

References

  • Ke C, Liang J, Liu M, Liu S, Wang C. Burden of chronic kidney disease and its risk-attributable burden in 137 low-and middle-income countries, 1990–2019: results from the global burden of disease study 2019. BMC Nephrol. 2022;23(1):1–12. doi:10.1186/S12882-021-02597-3/FIGURES/4
  • Liyanage T, Toyama T, Hockham C, et al. Prevalence of chronic kidney disease in Asia: a systematic review and analysis. BMJ Glob Health. 2022;7(1):e007525. doi:10.1136/BMJGH-2021-007525
  • National Institute of Health Research and Development. Main Results of Riskesdas 2018; 2018. Available from: https://kesmas.kemkes.go.id/assets/upload/dir_519d41d8cd98f00/files/Hasil-riskesdas-2018_1274.pdf. Accessed January 13, 2023.
  • Vadakedath S, Kandi V. Dialysis: a review of the mechanisms underlying complications in the management of chronic renal failure. Cureus. 2017;9(8):e1603. doi:10.7759/CUREUS.1603
  • Anees M, Butt G, Gull S, Nazeer A, Hussain I, Ibrahim M. Factors affecting dermatological manifestations in patients with end stage renal disease. J Coll Physicians Surg Pak. 2018;28(2):98–102. doi:10.29271/JCPSP.2018.02.98
  • Queeley GL, Campbell ES. Comparing treatment modalities for end-stage renal disease: a meta-analysis. Am Health Drug Benefits. 2018;11(3):127. doi:10.1016/j.jval.2014.03.1690
  • Yilmaz U, Inci A, Akarsu A, Maden U. Factors affecting the choice of renal replacement therapy in patients with end stage renal failure. Osmangazi J Med. 2022;44(4):499–507. doi:10.20515/OTD.1059206
  • Indonesian Renal Registry (IRR). 11th Report Of Indonesian Renal Registry 2018; 2018. Available from: https://www.indonesianrenalregistry.org/data/IRR%202018.pdf. Accessed January 13, 2023.
  • Vaidya SR, Aeddula NR, Doerr C. Chronic Renal Failure (Nursing). StatPearls Publishing; 2022. Available form: https://www.ncbi.nlm.nih.gov/books/NBK568778/. Accessed January 13, 2023.
  • Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017;389(10075):1238–1252. doi:10.1016/S0140-6736(16)32064-5
  • Nigam SK, Bush KT. Uraemic syndrome of chronic kidney disease: altered remote sensing and signalling. Nat Rev Nephrol. 2019;15(5):301–316. doi:10.1038/s41581-019-0111-1
  • Vanholder R, Fouque D, Glorieux G, et al. Clinical management of the uraemic syndrome in chronic kidney disease. Lancet Diabetes Nephrol. 2016;4(4):360–373. doi:10.1016/S2213-8587(16)00033-4
  • Falodun O, Ogunbiyi A, Salako B, George AK. Skin changes in patients with chronic renal failure. Saudi J Kidney Dis Transpl. 2011;22(2):272.
  • Khanna D, Singal A, Kalra OP. Comparison of cutaneous manifestations in chronic kidney disease with or without dialysis. Postgrad Med J. 2010;86(1021):641–647. doi:10.1136/PGMJ.2009.095745
  • Farhood IG, Naief ZR. Re-evaluation the frequency of cutaneous manifestations in patients on hemodialysis. Iraqi J Med Sci. 2013;11(4):388–392.
  • Kolla PK, Desai M, Pathapati RM, et al. Cutaneous manifestations in patients with chronic kidney disease on maintenance hemodialysis. ISRN Dermatol. 2012;2012:1–4. doi:10.5402/2012/679619
  • Nasir A, Shehzad A. Dermatological manifestations in patients with chronic kidney disease on regular hemodialysis. J Pak Assoc Dermatol. 2017;27(3):263–269.
  • Bouhamidi A, Amraoui M, Rafik H, Boui M, Hjira N. Dermatologic manifestations in patients on chronic hemodialysis. J Dermatol Res Ther. 2019;5(1):069. doi:10.23937/2469-5750/1510069
  • Mourad B, Hegab D, Okasha K, Rizk S. Prospective study on prevalence of dermatological changes in patients under hemodialysis in hemodialysis units in Tanta University hospitals, Egypt. Clin Cosmet Investig Dermatol. 2014;7:313–319. doi:10.2147/CCID.S70842
  • Udayakumar P, Balasubramanian S, Ramalingam KS, Lakshmi C, Srinivas CR, Mathew AC. Cutaneous manifestations in patients with chronic renal failure on hemodialysis. Indian J Dermatol Venereol Leprol. 2006;72(2):119–125. doi:10.4103/0378-6323.25636
  • Iftikhar U, Anees M, Nadeem M, Aman S, Kazmi AH. Frequency of cutaneous manifestations in patients of end stage renal disease on hemodialysis. Ann King Edw Med Univ. 2015;21(2):61. doi:10.21649/AKEMU.V21I2.699
  • Aggarwal H, Jain D, Yadav L, Aggarwal A, Singh J. Spectrum of skin manifestations in CKD: a tertiary care center experience from North India. Indian J Clin Pract. 2022;32(11):56.
  • Cheng AY, Wong LS. Uremic pruritus: from diagnosis to treatment. Diagnostics. 2022;12(5):1108. doi:10.3390/DIAGNOSTICS12051108
  • Szepietowski JC, Reich A, Schwartz RA. Uraemic xerosis. Nephrol Dial Transplant. 2004;19(11):2709–2712. doi:10.1093/NDT/GFH480
  • Kurniawan M, Regina R, Iryaningrum MR. The correlation between pruritus and xerosis with the quality of life of patients undergoing hemodialysis in Atma Jaya Hospital. J Pak Assoc Dermatol. 2022;32(2):288–292.
  • Kalicki RM, Farese S, Uehlinger DE. The validation of a new visual anaemia evaluation tool HemoHue HH1 in patients with end-stage renal disease. Anemia. 2013;2013:1–6. doi:10.1155/2013/424076
  • Anees M, Ibrahim M. Anemia and hypoalbuminemia at initiation of hemodialysis as risk factor for survival of dialysis patients. J Coll Physicians Surg Pak. 2009;19(12):776–780.
  • Population and Civil Registry Office. Population density based on district/city in West Java. Open Data Jabar. Available from: https://opendata.jabarprov.go.id/id/dataset/kepadatan-penduduk-berdasarkan-kabupatenkota-di-jawa-barat. Accessed July 18, 2022.
  • Serup J. EEMCO guidance for the assessment of dry skin (xerosis) and ichthyosis: clinical scoring systems. Skin Res Technol. 1995;1(3):109–114. doi:10.1111/J.1600-0846.1995.TB00029.X
  • Manenti L, Leuci E. Do you feel itchy? A guide towards diagnosis and measurement of chronic kidney disease-associated pruritus in dialysis patients. Clin Kid J. 2021;14(suppl. 3):i8–i15. doi:10.1093/CKJ/SFAB143
  • da Silva RM, Machado CA. Clinical evaluation of the paleness: agreement between observers and comparison with hemoglobin levels. Rev Bras Hematol Hemoter. 2010;32(6):444–448. doi:10.1590/S1516-84842010000600007
  • Bhatta S, Aryal G, Kafle R. Anemia in chronic kidney disease patients in predialysis and postdialysis stages. J Pathol Nepal. 2011;1(1):26–29. doi:10.3126/JPN.V1I1.4446
  • United States Renal Data System. 2022 USRDS Annual Data Report: epidemiology of Kidney Disease in the United States; 2022. Available from: https://usrds-adr.niddk.nih.gov/2022. Accessed January 13, 2023.
  • Maskey A, Kumar A, Shrestha R. Study of cutaneous manifestations in end stage kidney disease undergoing hemodialysis. Nepal J Dermatol Venereol Leprol. 2020;18(1):37–43. doi:10.3126/NJDVL.V18I1.29568
  • Agarwal P, Garg V, Karagaiah P, Szepietowski JC, Grabbe S, Goldust M. Chronic kidney disease-associated pruritus. Toxins. 2021;13(8):527. doi:10.3390/toxins13080527
  • Shafiee MA, Akbarian F, Memon KK, Aarabi M, Boroumand B. Dermatologic manifestations in end-stage renal disease. Iran J Kidney Dis. 2015;9(5):339–353.
  • Rezaiee Rezaiee O, Shahgholian N, Shahidi S. Assessment of hemodialysis adequacy and its relationship with individual and personal factors. Iran J Nurs Midwifery Res. 2016;21(6):577–582. doi:10.4103/1735-9066.197673
  • Ana-Sonia I, Mirela G, Iudita-Maria B, Mihail-Alexandru B, Elena L, Sliviu-Horia M. Cutaneous findings in chronic kidney disease and hemodialysis. Rom J Clin Exp Dermatol. 2015;2(3):182–189.
  • Ariyani H, Robby A. Pruritus overview of chronic kidney failure patients using visual analogue scale application in Hemodialysis Unit General Hospital dr. Soekardjo, Tasikmalaya City, West Java. J Phys Conf Ser. 2020;1477(6):62014. doi:10.1088/1742-6596/1477/6/062014
  • Daraghmeh M, Badran M, Janajreh A, et al. Prevalence of pruritus associated with hemodialysis and its association with sleep quality among hemodialysis patients: a multicenter study. BMC Nephrol. 2022;23(213):23. doi:10.1186/s12882-022-02838-z
  • Satti MZ, Arshad D, Javad H, et al. Uremic pruritus: prevalence and impact on quality of life and depressive symptoms in hemodialysis patients. Cureus. 2019;11(7):e5178. doi:10.7759/cureus.5178
  • Hamza E, Metzinger L, Metzinger-le Meuth V. Uremic toxins affect erythropoiesis during the course of chronic kidney disease: a review. Cells. 2020;9(9):2039. doi:10.3390/cells9092039
  • Coad J, Pedley K. Iron deficiency and iron deficiency anemia in women. Scand J Clin Lab Invest. 2014;74(suppl. 244):82–89. doi:10.3109/00365513.2014.936694